Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | |
| Sales | 194 | 0 |
| Gross Profit | 194 | N/A |
| Operating Expenses | 9,915 | 0 |
| Operating Income | -9,721 | N/A |
| Other Income | 1,054 | 0 |
| Pre-tax Income | -8,667 | 0 |
| Net Income Continuous | -8,667 | N/A |
| Net Income | $-8,667 | $N/A |
| EPS Basic Total Ops | -3.22 | N/A |
| EPS Basic Continuous Ops | -2.25 | N/A |
| EPS Diluted Total Ops | -3.22 | N/A |
| EPS Diluted Continuous Ops | -2.25 | N/A |
| EBITDA(a) | $-10,045 | $N/A |